NCT06606158 (HIP-App) is a clinical trial of Exercises program in Total Hip Arthroplasty, sponsored by Universidad Pontificia Comillas.

Who is sponsoring NCT06606158?

NCT06606158 is sponsored by Universidad Pontificia Comillas.

What drugs are being tested in NCT06606158?

Interventions in NCT06606158: Exercises program, App exercises program.

What condition does NCT06606158 study?

NCT06606158 studies Total Hip Arthroplasty.

Is NCT06606158 still recruiting?

NCT06606158 is currently completed. Last updated 13 November 2024.

Last reviewed 2024-11-13 · How we verify

NCT06606158: HIP-App

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rehabilitation in Total Hip Arthroplasty Through a Mobile Application

Completed Last updated 13 November 2024

What this trial tests

trial testing Exercises program in Total Hip Arthroplasty in 110 participants. Completed in 30 March 2024.

Timeline

1 July 2023

Primary endpoint
30 March 2024

30 March 2024

Quick facts

Lead sponsor	Universidad Pontificia Comillas
Status	Completed
Study type	OBSERVATIONAL
Enrollment	110
Start date	1 July 2023
Primary completion	30 March 2024
Estimated completion	30 March 2024
Sites	1 location across Spain

Drugs / interventions tested

Exercises program
App exercises program

Conditions studied

Total Hip Arthroplasty — all drugs for Total Hip Arthroplasty →

Sponsor

Universidad Pontificia Comillas

Who can join

18 and older, any sex, with Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational retrospective study aims to assess the rehabilitation outcomes of patients who underwent total hip arthroplasty (THA) and were monitored through a mobile application versus those who were not. The hypothesis is that patients who receive postoperative follow-up via a mobile app, which includes a recovery exercise program, will experience significantly greater improvements in functionality, quality of life, and treatment adherence compared to those who do not use the app after three months of follow-up. The study will analyze the records of patients from two cohorts: one group monitored with the mobile application and another group receiving standard postoperative care without the app. Data on patients\' functionality, quality of life, and adherence to treatment will be collected and compared between the two groups. This study seeks to provide evidence on the effectiveness of digital health interventions in enhancing postoperative recovery for THA patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Total hip arthroplasty rehabilitation through a mobile application: a retrospective observational study.
Zambrano-Martín J, Moreta J, Gómez-Conesa A, Méndez-Sánchez R, et al · · 2026 · PMID 41948908 · DOI 10.1177/11207000261423149

Verify or expand the search:

Other recruiting trials for Total Hip Arthroplasty

Currently open trials in the same condition.

NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
NCT07227064 — Methadone in THA for Post-op Pain and Opioid Reduction · Phase 3 · recruiting
NCT06768580 — Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Pati · NA · recruiting
NCT06904703 — Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty · NA · recruiting
NCT06356116 — Rehabilitation After Direct Anterior Approach for Total Hip Arthroplasty · NA · recruiting

Other Universidad Pontificia Comillas trials

Trials by the same sponsor.

NCT07207512 — Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder · NA · not yet recruiting
NCT07520864 — Effects of Caffeine on Elite Weightlifting Performance · NA · completed
NCT07497035 — Equine Therapy Programme on Stress, Autonomy and Balance in School-age Children With Intellectual Disabilities · NA · active not recruiting
NCT06727487 — OvS Breast: Ovarian Suppression in Breast Cancer Interventions · NA · recruiting
NCT07129863 — Caffeine Mouth Rinsing at Different Doses in Female Team-Sport Athletes: A Randomized, Double-Blind, Placebo-Controlled · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06606158 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Pontificia Comillas
Last refreshed: 13 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06606158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing